Global Oncology Academy

The Global Oncology Academy (GOA) is an educational platform for physicians and other healthcare professionals involved in oncology. Its mission is to increase knowledge regarding the disease course of specific cancers and address key elements for successful management. The GOA series will also share the science around innovations in combination therapies, oncology strategies, and new developments.

For more information about GOA, visit www.globaloncologyacademy.org.

Episodes 1-16 of 131

Selecting Patients for Novel Breast Cancer Imaging Modalities: The Role of AI
Selecting Patients for Novel Breast Cancer Imaging Modalities: The Role of AI
Project Oncology®
Selecting Patients for Novel Breast Cancer Imaging Modalities: The Role of AI
- Constance Lehman
Understanding Bone Metastases in Breast Cancer: Impacts and Treatment Approaches
Understanding Bone Metastases in Breast Cancer: Impacts and Treatment Approaches
Project Oncology®
Understanding Bone Metastases in Breast Cancer: Impacts and Treatment Approaches
- Rachelle W. Johnson, PhD
Supplements and Cannabis in Breast Cancer Care: An Integrative Medicine Approach
Supplements and Cannabis in Breast Cancer Care: An Integrative Medicine Approach
Project Oncology®
Supplements and Cannabis in Breast Cancer Care: An Integrative Medicine Approach
- Heather Greenlee, ND, PhD, MPH
The Potential Link Between COVID-19 and Cancer Regression
The Potential Link Between COVID-19 and Cancer Regression
Clinician's Roundtable
The Potential Link Between COVID-19 and Cancer Regression
- Ankit Bharat, MD
NSCLC Care: Predicting Response to Dato-DXd with a TROP2 Biomarker
NSCLC Care: Predicting Response to Dato-DXd with a TROP2 Biomarker
Project Oncology®
NSCLC Care: Predicting Response to Dato-DXd with a TROP2 Biomarker
- Jacob Sands, MD
- Marina Garassino, MD
CAR T-Cell Therapy for R/R Mantle Cell Lymphoma: Key Considerations
CAR T-Cell Therapy for R/R Mantle Cell Lymphoma: Key Considerations
Project Oncology®
CAR T-Cell Therapy for R/R Mantle Cell Lymphoma: Key Considerations
- Chenyu Lin, MD
- Charles Turck, PharmD, BCPS, BCCCP
Poster Pearl: Treating ER+/HER2- mBC with Elacestrant and Endocrine Therapy
Poster Pearl: Treating ER+/HER2- mBC with Elacestrant and Endocrine Therapy
Project Oncology®
Poster Pearl: Treating ER+/HER2- mBC with Elacestrant and Endocrine Therapy
- Charles Turck, PharmD, BCPS, BCCCP
- Hope S. Rugo, MD, FASCO
Optimizing mCRPC Care: Treatment Selection and Sequencing Strategies
Optimizing mCRPC Care: Treatment Selection and Sequencing Strategies
Project Oncology®
Optimizing mCRPC Care: Treatment Selection and Sequencing Strategies
- Charles Turck, PharmD, BCPS, BCCCP
- Hannah McManus, MD
- Andrew Armstrong, MD, MSc
Improving Adherence to CRC Screening: A Primary Care Physician’s Guide
Improving Adherence to CRC Screening: A Primary Care Physician’s Guide
Clinician's Roundtable
Improving Adherence to CRC Screening: A Primary Care Physician’s Guide
- Charles Turck, PharmD, BCPS, BCCCP
- Sara Enslin, PA
Enhancing Outcomes in Relapsed/Refractory B-ALL with CAR T-Cell Therapy
Enhancing Outcomes in Relapsed/Refractory B-ALL with CAR T-Cell Therapy
Project Oncology®
Enhancing Outcomes in Relapsed/Refractory B-ALL with CAR T-Cell Therapy
- Gates B. Colbert, MD
- Ryan Cassaday, MD
Examining Key Data on CAR T-Cell Therapy for Relapsed/Refractory MCL
Examining Key Data on CAR T-Cell Therapy for Relapsed/Refractory MCL
Project Oncology®
Examining Key Data on CAR T-Cell Therapy for Relapsed/Refractory MCL
- Jennifer Caudle, DO
- Matthew Matasar, MD
The Promise of MCED Testing: Easing the Burden of Cancer Screening Anxiety
The Promise of MCED Testing: Easing the Burden of Cancer Screening Anxiety
Project Oncology®
The Promise of MCED Testing: Easing the Burden of Cancer Screening Anxiety
- Charles Turck, PharmD, BCPS, BCCCP
- Christopher Chambers, MD
- Adam H. Buchanan, MS, MPH
Uncovering New Biomarkers for RCC: A Review of Emerging Techniques
Uncovering New Biomarkers for RCC: A Review of Emerging Techniques
Project Oncology®
Uncovering New Biomarkers for RCC: A Review of Emerging Techniques
- Jody Takemoto, PhD
- David Braun
Optimizing HCC Screening: Strategies to Overcome Common Barriers
Optimizing HCC Screening: Strategies to Overcome Common Barriers
Project Oncology®
Optimizing HCC Screening: Strategies to Overcome Common Barriers
- Hannah Lee, MD
Enhancing HCC Outcomes Through Multidisciplinary Care
Enhancing HCC Outcomes Through Multidisciplinary Care
Project Oncology®
Enhancing HCC Outcomes Through Multidisciplinary Care
- Charles Turck, PharmD, BCPS, BCCCP
- Hannah Lee, MD
The Potential Impact of RCC Molecular Subtypes on Treatment Outcomes
The Potential Impact of RCC Molecular Subtypes on Treatment Outcomes
Project Oncology®
The Potential Impact of RCC Molecular Subtypes on Treatment Outcomes
- Jody Takemoto, PhD
- David Braun, MD, PhD